CC BY-NC-ND 4.0 · J Lab Physicians 2022; 14(01): 021-026
DOI: 10.1055/s-0041-1734017
Original Article

Circulation of DENV-3 Genotype 3 during 2017 to 2018 in Delhi: A Single-Center Hospital-Based Study

Abhishek Padhi
1   Department of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi, Delhi, India
,
Ekta Gupta
1   Department of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi, Delhi, India
,
Gaurav Singh
1   Department of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi, Delhi, India
,
Shama Parveen
2   Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, Delhi, India
,
Arshi Islam
2   Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, Delhi, India
,
Bansidhar Tarai
3   Department of Microbiology and Infection Control, Max Superspeciality Hospital, New Delhi, Delhi, India
› Author Affiliations
Funding None.

Abstract

Introduction Delhi is hyperendemic for dengue virus (DENV) where all the four DENV have previously been reported. A constant vigilance of circulating DENV serotypes is important in surveillance, since the introduction of a new variant to areas affected by preexisting serotypes constitutes a risk factor for dengue hemorrhagic fever and dengue shock syndrome.

Objectives This retrospective study was performed with an objective to determine the circulating serotype and genotype of DENV in acute phase blood samples of patients who have reported to a tertiary liver care hospital in New Delhi during the last 2 years (2017–2018).

Methods The data of clinician-initiated testing for dengue nonstructural protein 1 (NS1) antigen (Ag) was searched in the institutional hospital information system. The serum sample of dengue NS1 Ag-positive cases confirmed by enzyme-linked immunosorbent assay (ELISA; PANBIO, Gyeonggi-do, ROK) and a fever duration of less than 5 days were retrieved from the laboratory archive. The DENV serotyping on these sample was performed by reverse transcriptase polymerase chain reaction (RT-PCR). Sequencing and phylogenetic analysis was done for the capsid premembrane (CprM) region to determine the genotype.

Results A total of 440 acute-phase samples were received. Twenty one (4.77%) were positive for dengue NS1 Ag with a mean age of 35.1 years and male-to-female ratio of 1.1:1. Eight cases (38.09%) were positive by dengue RT-PCR and all belonged to DENV-3 serotypes. Phylogenetic tree analysis revealed DENV-3 clustered to genotype III with 100% homology with 2008 Indian subcontinent strain.

Conclusion This study revealed circulation of DENV-3, genotype III in Delhi from 2017 to 2018, similar to the 2008 viral type. Virological surveillance is an important exercise to be done for viral infections with public threat and outbreak potential.



Publication History

Article published online:
14 September 2021

© 2021. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 World Health Organization. Dengue and severe dengue. Available at: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue
  • 2 Bhatt S, Gething PW, Brady OJ. et al. The global distribution and burden of dengue. Nature 2013; 496 (7446): 504-507
  • 3 Guzman MG, Gubter DJ, Izquierdo A, Martinez E, Halstead SB. Dengue infection. Accessed March 14, 2020 at: https://www.nature.com/articles/nrdp201655?draft=collection&proof=true
  • 4 Chen R, Vasilakis N. Dengue–quo tu et quo vadis?. Viruses 2011; 3 (09) 1562-1608
  • 5 Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res 2002; 33 (04) 330-342
  • 6 Guzman MG, Vazquez S. The complexity of antibody-dependent enhancement of dengue virus infection. Viruses 2010; 2 (12) 2649-2662
  • 7 Grange L, Simon-Loriere E, Sakuntabhai A, Gresh L, Paul R, Harris E. Epidemiological risk factors associated with high global frequency of inapparent dengue virus infections. Front Immunol 2014; 5: 280
  • 8 Dar L, Gupta E, Narang P, Broor S. Cocirculation of dengue serotypes, Delhi, India, 2003. Emerg Infect Dis 2006; 12 (02) 352-353
  • 9 Kukreti H, Mittal V, Chaudhary A. et al. Continued persistence of a single genotype of dengue virus type-3 (DENV-3) in Delhi, India since its re-emergence over the last decade. J Microbiol Immunol Infect 2010; 43 (01) 53-61
  • 10 Gupta E, Dar L, Kapoor G, Broor S. The changing epidemiology of dengue in Delhi, India. Virol J 2006; 3: 92
  • 11 Gupta E, Mohan S, Bajpai M, Choudhary A, Singh G. Circulation of dengue virus-1 (DENV-1) serotype in Delhi, during 2010-11 after dengue virus-3 (DENV-3) predominance: a single centre hospital-based study. J Vector Borne Dis 2012; 49 (02) 82-85
  • 12 World Health Organization. Dengue Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition. Geneva, Switzerland: World Health Organization; 2009
  • 13 Lanciotti RS, Calisher CH, Gubler DJ, Chang G-J, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992; 30: 7
  • 14 Laboratory diagnosis and diagnostic tests. In: Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition. Geneva, Switzerland: World Health Organization; 2009
  • 15 Klungthong C, Gibbons RV, Thaisomboonsuk B. et al. Dengue virus detection using whole blood for reverse transcriptase PCR and virus isolation. J Clin Microbiol 2007; 45 (08) 2480-2485
  • 16 Gore MM. Need for constant monitoring of dengue infections. Indian J Med Res 2005; 121 (01) 9-12
  • 17 National Health Mission, India. National vector borne disease control programme. Accessed October 24, 2020 at: https://nvbdcp.gov.in/index4.php?lang=1&level=0&linkid=431&lid=3715
  • 18 Kukreti H, Chaudhary A, Rautela RS. et al. Emergence of an independent lineage of dengue virus type 1 (DENV-1) and its co-circulation with predominant DENV-3 during the 2006 dengue fever outbreak in Delhi. Int J Infect Dis 2008; 12 (05) 542-549
  • 19 Dash PK, Parida MM, Saxena P. et al. Emergence and continued circulation of dengue-2 (genotype IV) virus strains in northern India. J Med Virol 2004; 74 (02) 314-322
  • 20 Singh P, Mittal V, Rizvi MMA. et al. The first dominant co-circulation of both dengue and chikungunya viruses during the post-monsoon period of 2010 in Delhi, India. Epidemiol Infect 2012; 140 (07) 1337-1342
  • 21 Singh UB, Maitra A, Broor S, Rai A, Pasha ST, Seth P. Partial nucleotide sequencing and molecular evolution of epidemic causing dengue 2 strains. J Infect Dis 1999; 180 (04) 959-965
  • 22 Parveen N, Islam A, Tazeen A. et al. Circulation of single serotype of dengue virus (DENV-3) in New Delhi, India during 2016: a change in the epidemiological trend. J Infect Public Health 2019; 12 (01) 49-56
  • 23 Suleman M, Faryal R, Alam MM. et al. Outbreak of dengue virus type-3 in Malakand, Pakistan 2015; a laboratory perspective. Acta Trop 2017; 169: 202-206
  • 24 Koo C, Nasir A, Hapuarachchi HC. et al. Evolution and heterogeneity of multiple serotypes of Dengue virus in Pakistan, 2006-2011. Virol J 2013; 10 (01) 275
  • 25 Sharma S, Dash PK, Agarwal S, Shukla J, Parida MM, Rao PVL. Comparative complete genome analysis of dengue virus type 3 circulating in India between 2003 and 2008. J Gen Virol 2011; 92 (Pt 7): 1595-1600
  • 26 Dash PK, Parida MM, Saxena P. et al. Reemergence of dengue virus type-3 (subtype-III) in India: implications for increased incidence of DHF & DSS. Virol J 2006; 3: 55
  • 27 Messer WB, Gubler DJ, Harris E, Sivananthan K, de Silva AM. Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis 2003; 9 (07) 800-809
  • 28 Dar L, Broor S, Sengupta S, Xess I, Seth P. The first major outbreak of dengue hemorrhagic fever in Delhi, India. Emerg Infect Dis 1999; 5 (04) 589-590
  • 29 Vajpayee M, Mohankumar K, Wali JP, Dar L, Seth P, Broor S. Dengue virus infection during post-epidemic period in Delhi, India. Southeast Asian J Trop Med Public Health 1999; 30 (03) 507-510
  • 30 Bharaj P, Chahar HS, Pandey A. et al. Concurrent infections by all four dengue virus serotypes during an outbreak of dengue in 2006 in Delhi, India. Virol J 2008; 5: 1
  • 31 Chakravarti A, Kumar A, Matlani M. Displacement of dengue virus type 3 and type 2 by dengue virus type 1 in Delhi during 2008. Indian J Med Microbiol 2010; 28 (04) 412
  • 32 Afreen N, Naqvi IH, Broor S, Ahmed A, Parveen S. Phylogenetic and molecular clock analysis of dengue serotype 1 and 3 from New Delhi, India. PLoS One 2015; 10 (11) e0141628
  • 33 Choudhary MC, Gupta E, Sharma S, Hasnain N, Agarwala P. Genetic signatures coupled with lineage shift characterise endemic evolution of dengue virus serotype 2 during 2015 outbreak in Delhi, India. Trop Med Int Health 2017; 22 (07) 871-880